Products

What will AGI do for Aztreonam?

This classification denotes a beta-lactam antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G2B4VE5GH8. European Medicines Agency schedules Aztreonam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05664MIG. Aztreonam generally arises in the molecular formula C13H17N5O8S2. The term AZTREONAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, no. 6, 1983, list 23.) AZTREONAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule aztreonam under HS 29419000 and SITC 54139. As of Q4 2014, AZTREONAM remains the US FDA Preferred Term for this commodity. Aztreonam bears US NLM identifiers UMLS ID C0699281 and NCI Concept Code C28845. SMILES: S(=O)(=O)(O)N1C(C(NC(=O)/C(=N\OC(C)(C)C(=O)O)C2NC(SC2)[NH3])C1=O)C.